Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inGenetics

Impact of Early Life Adversity on Epigenome at Molecular Level Mapped in Macaques

June 18, 2026
Continue Reading
impact-of-early-life-adversity-on-epigenome-at-molecular-level-mapped-in-macaques
Posted inGenetics

Historic Biotech IPO, Merck, Protillion’s AI Deal, Testing a Lassa–Rabies Vaccine

June 18, 2026
Continue Reading
historic-biotech-ipo,-merck,-protillion’s-ai-deal,-testing-a-lassa–rabies-vaccine
Posted inGenetics

IDBS and Alchemi Agree to Accelerate AI-Driven Biopharma Regulatory Filings

June 18, 2026
Continue Reading
idbs-and-alchemi-agree-to-accelerate-ai-driven-biopharma-regulatory-filings
Posted inBiotechnology

Moderna’s flu candidate sails through FDA advisory committee in unanimous votes

June 18, 2026
Continue Reading
moderna’s-flu-candidate-sails-through-fda-advisory-committee-in-unanimous-votes
Posted inGenetics

China Sets Framework for Advanced Therapeutic Development

June 18, 2026
Continue Reading
china-sets-framework-for-advanced-therapeutic-development
Posted inGenetics

Perseverance, Persistence Key to CAR T Success, Say Ross Prize Winners Carl June and Michel Sadelain

June 18, 2026
Continue Reading
perseverance,-persistence-key-to-car-t-success,-say-ross-prize-winners-carl-june-and-michel-sadelain
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

novo-holdings-leads-siteone’s-$100m-series-c-for-non-opioid-pain-treatments
Posted inBiotechnology

Novo Holdings leads SiteOne’s $100M series C for non-opioid pain treatments

December 17, 2024
SiteOne Therapeutics is powering up with $100 million to advance its early pipeline of non-opioid therapeutics that target the peripheral…
Read More
ketamine-keeps-zebrafish-from-giving-up-by-overstimulating-astroglia
Posted inGenetics

Ketamine Keeps Zebrafish from Giving up by Overstimulating Astroglia

December 17, 2024
The anesthetic ketamine could be a game changer for treating severe depression, but there are still many questions about how…
Read More
bd,-babson-diagnostics-expand-fingertip-blood-draws-to-urgent-care-clinics,-doctors’-offices
Posted inMedical Technology

BD, Babson Diagnostics expand fingertip blood draws to urgent care clinics, doctors’ offices

December 17, 2024
Longtime partners in simplifying blood sample collection and testing, BD and Babson Diagnostics are now making their miniaturized approach available…
Read More
dexcom-taps-generative-ai-lifestyle-tips-for-its-stelo-glucose-sensor
Posted inMedical Technology

Dexcom taps generative AI lifestyle tips for its Stelo glucose sensor

December 17, 2024
Dexcom has launched a generative AI platform aimed at providing personalized lifestyle tips to the users of its over-the-counter wearable…
Read More
sanofi,-teva-look-to-‘next-frontier’-in-ibd-treatment-after-tl1a-antibody-hits-mark-in-midstage-trial
Posted inBiotechnology

Sanofi, Teva look to ‘next frontier’ in IBD treatment after TL1A antibody hits mark in midstage trial

December 17, 2024
As Merck and Roche continue to march their respective inflammatory bowel disease (IBD) assets through the clinic, Sanofi and Teva…
Read More
biomea’s-diabetes-drug-improves-glucose-control-3-months-after-fda-hold-lifted
Posted inBiotechnology

Biomea’s diabetes drug improves glucose control 3 months after FDA hold lifted

December 17, 2024
Three months after Biomea Fusion’s menin inhibitor was released from a clinical hold, the company has claimed a win in…
Read More
cash-strapped-portage-finds-hope-in-sale-of-lead-asset,-subsidiary-to-immunova
Posted inBiotechnology

Cash-strapped Portage finds hope in sale of lead asset, subsidiary to Immunova

December 17, 2024
After spending most of the year hunting for options to stay afloat, cash-strapped Portage Biotech appears to have found salvation…
Read More
fresh-off-$120m-raise,-ai-powered-terray-is-teaming-up-with-gilead-in-multi-pronged-r&d-pact
Posted inBiotechnology

Fresh off $120M raise, AI-powered Terray is teaming up with Gilead in multi-pronged R&D pact

December 17, 2024
Terray is ending the year on a high. Just two short months ago the biotech came out with a healthy…
Read More
fierce-biotech’s-top-10-editor’s-picks-for-2024
Posted inBiotechnology

Fierce Biotech’s top 10 editor’s picks for 2024

December 17, 2024
The year kicked off with a flurry of dealmaking at the J.P. Morgan Healthcare Conference in January, and the pace…
Read More
merck-drops-tigit-asset-and-lag-3-program,-discontinuing-several-phase-3-trials
Posted inBiotechnology

Merck drops TIGIT asset and LAG-3 program, discontinuing several phase 3 trials

December 16, 2024
Out with the old, in with the new. The end of the year in biopharma is typically marked by pipeline…
Read More

Posts pagination

Previous page 1 … 1,979 1,980 1,981 1,982 1,983 … 1,989 Next page
You May Have Missed
novocure-device-fails-to-improve-brain-cancer-patients’-survival-in-phase-3-test
Posted inMedical Technology

Novocure device fails to improve brain cancer patients’ survival in phase 3 test

fda-clears-dexcom’s-stelo-otc-glucose-monitor-for-use-with-children
Posted inMedical Technology

FDA clears Dexcom’s Stelo OTC glucose monitor for use with children

irhythm-hit-by-cyberattack-that-compromised-patient-data,-says-operations-unaffected
Posted inMedical Technology

iRhythm hit by cyberattack that compromised patient data, says operations unaffected

amid-us-investment-tour,-j&j-makes-$1b-stop-in-florida-to-upgrade-contact-lens-plant
Posted inMedical Technology

Amid US investment tour, J&J makes $1B stop in Florida to upgrade contact lens plant

Privacy Policy    Terms

Scroll to Top